AI assistant
EBOS GROUP LIMITED — Director's Dealing 2019
Apr 8, 2019
64813_rns_2019-04-08_3df29239-ce4e-41d9-9188-fe2f0534a19e.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 9-Apr-19 | |
| Date of last disclosure: | 26-Mar-19 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | Mark Waller | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Director | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class of affected quoted financial products: | Ordinary | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to dividend | |
| reinvestmentplan | ||
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 500,265 | |
| Number held in class after acquisition or disposal: | 506,692 | |
| Current registered holder(s): | Mark Brendon Waller & Angela | |
| Laura Waller | ||
| Registered holder(s) once transfers are registered: | Mark Brendon Waller & Angela Laura Waller |
|
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | ||
| Type of affected derivative: | ||
| Class of underlyingfinancialproducts: | ||
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial | ||
| products(if any): | ||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expirydate of the derivative(if any): | ||
| Theprice specified in the terms of the derivative(if any): | ||
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the | ||
| underlying financial products: | ||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | ||
| interestinthe derivative: | ||
| Details of transactions giving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | 1 | |
| Details of transactions requiring disclosure- | ||
| Date oftransaction: | 5-Apr-19 | |
| Issue of shares pursuant to dividend | ||
| Nature of transaction: | reinvestmentplan |
| Name ofany otherparty orparties to the transaction(if known): | N/A | N/A | |
|---|---|---|---|
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
$135,738.24 | ||
| Numberof financialproducts towhichthe transaction related: | 6,427 ordinaryshares | ||
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
|||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | ||
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | ||
| Date of theprior written clearance(if any): | N/A | ||
| Summary of other relevant interests after acquisition or disposal: Class ofquotedfinancialproducts: Nature of relevantinterest: For that relevant interest,- Number heldinclass: Currentregisteredholder(s): For a derivative relevant interest,- Type ofderivative: Details of derivative,- |
|||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
|||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
|||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
| Certification | ||
|---|---|---|
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 9-Apr-19 | |
| Name and title of authorised person: | Janelle Cain, General Counsel, EBOS Group Limited |
|
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 9-Apr-19 | |
| Date of last disclosure: | 9-Nov-15 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | Sarah Ottrey | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Director | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class of affected quoted financial products: Ordinary Nature of the affected relevant interest(s): Issue of shares pursuant to dividend reinvestmentplan For that relevant interest- |
||
| Class of affected quoted financial products: | Ordinary | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to dividend reinvestmentplan |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 8079 ordinaryshares | |
| Number held in class after acquisition or disposal: | 8176 ordinaryshares | |
| Current registered holder(s): | Sarah Christine Ottrey & Peter Calder Groves |
|
| Registered holder(s) once transfers are registered: | Sarah Christine Ottrey & Peter Calder Groves |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: Class of underlying financial products: Details of affected derivative- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative(if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
| Details of transactions giving rise to acquisition or disposal | ||
|---|---|---|
| Total numberoftransactions towhich noticerelates: | 1 | |
| 5-Apr-19 |
Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
Issue of shares pursuant to dividend reinvestment plan N/A $2,048.64 97 ordinary shares No N/A N/A
Summary of other relevant interests after acquisition or disposal:
| Summary of other relevant interests after acquisition or disposal: | |||
|---|---|---|---|
| Class ofquotedfinancialproducts: | Ordinary | ||
| Nature of relevantinterest: | Beneficial interest | ||
| _For that relevant interest,- _ | |||
| Number heldinclass: | 3050 ordinaryshares | ||
| FNZ Nominees Limited which holds | |||
| shares on behalf of The Phil Ingham | |||
| Currentregisteredholder(s): | FamilyTrust | ||
| For a derivative relevant interest,- | |||
| Type ofderivative: | |||
| Details of derivative,- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial | |||
| products (if any): | |||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable | |||
| under the derivative or the value of the derivative is affected by the value of the | |||
| underlyingfinancialproducts: | |||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | |||
| interest in the derivative: |
Certification
| Certification | ||
|---|---|---|
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 9-Apr-19 | |
| Name and title of authorised person: | Janelle Cain, General Counsel, EBOS Group Limited |
|
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 9-Apr-19 | |
| Date of last disclosure: | 22-Sep-17 | |
| Director or senior manager giving disclosure | ||
Full name(s): |
Sean Duggan | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | Chief Executive Officer, Animal Care & Consumer Brands |
|
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Class ofaffected quotedfinancialproducts: Nature of the affected relevant interest(s): For that relevant interest- Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): |
||
| Class ofaffected quotedfinancialproducts: | Ordinaryshares in EBOS GroupLimited | |
| Nature of the affected relevant interest(s): | Issue of shares pursuant to dividend reinvestmentplan |
|
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 306 ordinaryshares | |
| Number held in class after acquisition or disposal: | 310 ordinaryshares | |
| Current registered holder(s): | Sean Duggan | |
| Registeredholder(s) once transfers areregistered: | Sean Duggan | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab | le) | |
| Type of affected derivative: | N/A | |
| Class of underlyingfinancialproducts: | N/A | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
N/A | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | |
| Maturitydate of the derivative(if any): | N/A | |
| Expirydate of the derivative(if any): | N/A | |
| Theprice specified in the terms of the derivative(if any): | N/A | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
N/A | |
| _For that derivative,- _ | ||
| Parties to the derivative: | N/A | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interestinthe derivative: |
N/A | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | 1 | |
| 5-Apr-19 | ||
| Issue of shares pursuant to dividend reinvestmentplan |
||
| N/A | ||
| $84.48 | ||
| 4 ordinaryshares | ||
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | |
|---|---|---|
| Whether prior written clearance was provided to allow the acquisition or disposal to | ||
| proceed duringthe closedperiod: | N/A | |
| Date of theprior written clearance(if any): | N/A | |
| Summary of other relevant interests after acquisition or disposal: | ||
| Class ofquotedfinancialproducts: | Ordinaryshares | |
| Nature of relevant interest: | 1. Registered holder - 2016 long term | |
| incentive plan | ||
| 2. Registered holder - 2017 long term | ||
| incentiveplan | ||
| _For that relevant interest,- _ | ||
| 1. 45,000 ordinary shares | ||
| Number heldinclass: | 2. 50,000 ordinaryshares | |
| Currentregisteredholder(s): | Sean Duggan | |
| For a derivative relevant interest,- | ||
| Type ofderivative: | N/A |
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | No | |
|---|---|---|---|
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
N/A | ||
| Date of theprior written clearance(if any): | N/A | ||
| Summary of other relevant interests after acquisition or disposal: | |||
| Class ofquotedfinancialproducts: | Ordinaryshares | ||
| Nature of relevant interest: | 1. Registered holder - 2016 long term incentive plan 2. Registered holder - 2017 long term incentiveplan |
||
| _For that relevant interest,- _ | |||
| Number heldinclass: | 1. 45,000 ordinary shares 2. 50,000 ordinaryshares |
||
| Currentregisteredholder(s): | Sean Duggan | ||
| For a derivative relevant interest,- | |||
| Type ofderivative: | N/A | ||
| Details of derivative,- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
|||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlyingfinancialproducts: |
|||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
|||
| Certification | 9-Apr-19 Janelle Cain, General Counsel, EBOS Group Limited |
||
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
|||
| Signature of director or officer: | |||
| Date of signature: | |||
| or | |||
| Signature of person authorised to sign on behalf of director or officer: | |||
| Date of signature: | |||
| Name and title of authorised person: | |||